Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus.

UNLABELLED Diabetes mellitus is a common chronic disease affecting millions of people world wide. Standard treatment is failing to achieve required correction of blood glucose in many patients. Therefore, there is a need for investigating potential hypoglycemic drugs or herbs to improve glycemic control in diabetic patients. Nigella sativa seeds were used as an adjuvant therapy in patients with diabetes mellitus type 2 added to their anti-diabetic medications. A total of 94 patient were recruited and divided randomly into three dose groups. Capsules containing Nigella sativa were administered orally in a dose of 1, 2 and 3 gm/day for three months. The effect of Nigella sativa on the glycemic control was assessed through measurement of fasting blood glucose (FBG), blood glucose level 2 hours postprandially (2 hPG), and glycosylated hemoglobin (HbA1c). Serum C-peptide and changes in body weight were also measured. Insulin resistance and beta-cell function were calculated usin the homeostatic model assessment (HOMA2). Nigella sativa at a dose of 2 gm/day caused significant reductions in FBG, 2hPG, and HbA1 without significant change in body weight. Fasting blood glucose was reduced by an average of 45, 62 and 56 mg/dl at 4, 8 and 12 weeks respectively. HbAlC was reduced by 1.52% at the end of the 12 weeks of treatment (P<0.0001). Insulin resistance calculated by HOMA2 was reduced significantly (P<0.01), while B-cell function was increased (P<0.02) at 12 weeks of treatment. The use of Nigella sativa in a dose of 1 gm/day also showed trends in improvement in all the measured parameters but it was not statistically significant from the baseline. However, no further increment in the beneficial response was observed with the 3 gm/day dose. The three doses of Nigella sativa used in the study did not adversely affect either renal functions or hepatic functions of the diabetic patients throughout the study period. IN CONCLUSION the results of this study indicate that a dose of 2 gm/ day of Nigella sativa might be a beneficial adjuvant to oral hypoglycemic agents in type 2 diabetic patients.

[1]  M. Siegel,et al.  Glucose control in the ICU--how tight is too tight? , 2009, The New England journal of medicine.

[2]  M. Kartal,et al.  Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats. , 2007, Acta histochemica.

[3]  Liegang Liu,et al.  Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. , 2007, Clinical science.

[4]  M. Khattab,et al.  Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats , 2007, Phytotherapy research : PTR.

[5]  B. Lyoussi,et al.  Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). , 2007, Journal of ethnopharmacology.

[6]  M. Asif,et al.  Biochemical effects of Nigella sativa L seeds in diabetic rats. , 2006, Indian journal of experimental biology.

[7]  E. Lander,et al.  Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.

[8]  Z. Kerem,et al.  The Use of Medicinal Herbs by Diabetic Jordanian Patients , 2006, Journal of herbal pharmacotherapy.

[9]  N. Bashan,et al.  Proposed mechanisms for the induction of insulin resistance by oxidative stress. , 2005, Antioxidants & redox signaling.

[10]  M. Salem.  Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. , 2005, International immunopharmacology.

[11]  P. Haddad,et al.  The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. , 2004, Journal of ethnopharmacology.

[12]  Y. Atoji,et al.  Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. , 2004, Research in veterinary science.

[13]  H. Chevassus,et al.  Nigella sativa seed extracts enhance glucose‐induced insulin release from rat‐isolated Langerhans islets , 2004, Fundamental & clinical pharmacology.

[14]  M. Kanter,et al.  Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[15]  I. Meral,et al.  Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. , 2003, The Tohoku journal of experimental medicine.

[16]  H. Özbek,et al.  The role of Urtica dioica and Nigella sativa in the prevention of carbon tetrachloride‐induced hepatotoxicity in rats , 2003, Phytotherapy research : PTR.

[17]  B. Ali,et al.  Pharmacological and toxicological properties of Nigella sativa , 2003, Phytotherapy research : PTR.

[18]  M. Cakir,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2003, The Journal of clinical endocrinology and metabolism.

[19]  Y. Atoji,et al.  Isulinotropic properties of Nigella sativa oil in Streptozotocin plus Nicotinamide diabetic hamster. , 2002, Research in veterinary science.

[20]  N. Lembert,et al.  The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. , 2002, Planta medica.

[21]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[22]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.

[23]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[24]  K. Gumaa,et al.  Studies on the activity of individual plants of an antidiabetic plant mixture , 1988, Acta diabetologia latina.

[25]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[26]  M. Sayed,et al.  Traditional medicine in health care. , 1980, Journal of ethnopharmacology.

[27]  K. M. Nadkarni.  The Indian Materia Medica , 1927, The Indian Medical Gazette.

[28]  M. S. Al-Ghamdi.  Protective effect of Nigella sativa seeds against carbon tetrachloride-induced liver damage. , 2003, The American journal of Chinese medicine.

[29]  A. Al-Hader,et al.  Hypoglycemic Effects of the Volatile Oil of Nigella sativa Seeds , 1993 .